MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue132,499166,858177,389
Cost of Revenue88,026109,927121,379
Gross Profit44,47356,93156,010
Operating Expenses
Research Development1,8694,2513,997
Selling General and Administrative50,36184,33471,389
Non Recurring90118,29318,293
Total Operating Expenses---
Operating Income or Loss-8,658-49,947-19,376
Income from Continuing Operations
Total Other Income/Expenses Net5,499-1,8065,577
Earnings Before Interest and Taxes-3,159-51,753-13,799
Interest Expense---
Income Before Tax-3,159-51,753-13,799
Income Tax Expense31810533
Minority Interest---
Net Income From Continuing Ops-3,477-51,858-13,832
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,477-51,858-13,832
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,477-51,858-13,832